Recruiting

Diet App

Sponsor:

University of Alberta

Code:

NCT06683105

Conditions

Inflammatory Bowel Disease (IBD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MyIBDDiet app

Study Details

Brief summary:

The goal of this clinical trial is to learn if an app designed for diet education can help patients with inflammatory bowel disease (IBD) learn about healthy eating.

The main question\[s\] it aims to answer are:

  • Is the app easy to use?
  • Is the app useful? Researchers will compare the diet app to see if it is better at teaching patients about a healthy diet than the standard information they may receive from their doctor.

Participants will be asked to use the app for one month and answer surveys to see how easy the app is to use and if it leads to healthier eating.

Conditions

Inflammatory Bowel Disease (IBD)

Study ID

NCT06683105

Start date

Mar 15, 2026

Status verified date

May, 2026

Completion date

Jun 1, 2029

Anticipated

Primary completion date

Dec 1, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. ≥18 years
2. Able to provide informed consent
3. Established diagnosis of IBD determined by treating physician
4. Not in acute flare
5. Not pregnant
6. Willing and able to comply with all required study procedures

Exclusion Criteria:

1. Short bowel syndrome
2. High ostomy output
3. Intestinal strictures
4. Pregnancy or breastfeeding
5. Malnutrition (evaluated by Canadian Nutrition Screening Tool (CNST) )
6. Conditions requiring dietary restrictions (e.g. Celiac disease, kidney disease, diabetes, eosinophilic esophagitis)
7. Have other conditions that may require low fibre diet such as irritable bowel syndrome, gastroparesis.
8. Currently on a therapeutic diet
9. Already on a diet for IBD or using diet tool for IBD (e.g. Mediterranean or anti-inflammatory diet)
10. Active malignancy

Study Design

Enrollment

40 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Other

Interventions and Outcome Measures

Arms

active comparator: Control Crossover Arm

This group will not use the app for the first 30 days, then begin using it for the following 30 days.

experimental: MyIBDDiet users

This group will use the MyIBDDiet app for 60 days and compared with the control group.

Interventions

MyIBDDiet app

Participants in the Control crossover arm will be administered the intervention (using the app) for 30 days, and participants in the MYIBDDiet arm will use the app for 60 days.

Primary outcome measure

  • Usability of MyIBDDiet App [ Time Frame: Through study completion - 60 days ]
  • Acceptability [ Time Frame: Through study completion - 60 days ]

Central Contacts and Locations

Central contacts

Karen Wong, MD, FRCPC

780-492-8691kwong3@ualberta.ca

Ravneet Kaur, M.Sc.

7802481034rkaur8@ualberta.ca

Locations

Zeidler Ledcor Centre, University of Alberta

Recruiting

Edmonton, Alberta, Canada, T6G 2X8

Contacts

Karen Wong, MD, FRCPC

780-492-8691kwong3@ualberta.ca

More Information

Sponsor

University of Alberta

Last update posted

May 7, 2026

Last verified

May, 2026

Keywords

  • Inflammatory Bowel Disease (IBD)
  • Crohn's disease
  • Ulcerative colitis
  • Self-management
  • Malnutrition
  • Mediterranean diet
  • Mobile health applications

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Alberta on 2026-05-07.